Інтерлейкін-2-продукуюча активність лімфоцитів у хворих на рак щитоподібної залози у процесі радіойодтерапії

Н. М. Степура, Г. А. Замотаєва

Анотація


The authors present the data on a study of the effect of iodine-131 on interleukin-2-producing activity of lymphocytes in patients with thyroid cancer depending on distant metastases and the number of radioiodine therapy courses. With this purpose, 119 patients have been followed up. The group "A" comprised 49 patients with regional metastases and Group "B" – 70 patients with distant metastases. Depending on the number of radioiodine therapy courses patients were divided into six groups. The age of patients ranged from 38 to 75 years. The control group included 22 practically healthy age-matched donors. Assessment of interleukin-2-producing activity of lymphocytes was performed at the eve and in 6 days, one and 6 months after radioiodine therapy. Administration of therapeutic iodine-131 activity (from 4130 to 4730 MBq) was found to lead to a reliable decrease in the index under study. The lowest values of interleukin-2-producing activity of lymphocytes were reported in one month after radioiodine therapy in patients with regional metastases, and in case of metastases to lungs such a decrease was noted earlier (on day 6). It has also been shown that with increasing total exposure dose received by the patients in the process of repeated radioiodine therapy courses, interleukin-2-producing activity of lymphocytes was decreasing.

Ключові слова


differentiated thyroid cancer; radioiodine therapy; iodine-131; interleukin-2-producing activity of lymphocytes; cumulative activity

Повний текст:

PDF

Посилання


Shore R.T. Issues and epidemiological evidence regarding radiation-induced thyroid cancer / R.T. Shore // Radiat. Res. – 1992. – Vol. 131, № 1. – P. 98-111. https://doi.org/10.2307/3578322

Thyroid cancer risk in areas of Ukraine and Belarus affected by the Chernobyl accident / P. Jacob, T.I. Bogdanova, E. Buglova [et al.] // Radiat. Res. – 2006. – Vol. 165, № 1. – P. 1-8. https://doi.org/10.1667/rr3479.1

Dose-response relationships for radiatin-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid / A.B. Schneider, E. Ron, J. Lubin [et.al] // J. Clin. Endocrinol. Metab. – 1993. – № 7. – P. 362-369. https://doi.org/10.1210/jcem.77.2.8345040

Biological dosimetry in patients treated with iodine 131 for differentiated thyroid carcinoma/ R. M'Kacher, J.D. Legal, M. Schlumberger [et al.]//J. Nucl. Med. – 1996. – № 37. – P. 1860-1864.

Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131/R. M`Kacher, M. Schlumberger, J.D. Legal [et al.]//J. Nucl. Med. – 1998. – № 39(5). – P. 825-929.

Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test / S. Gutierrez, E. Carbonell, P. Galofre [et al.] // Eur. J. Nucl. Med. – 1999. – Vol. 26, № 12. – P. 1589-1596. https://doi.org/10.1007/s002590050499

Possible transient adaptive response to mitomycin C in peripheral lymphocytes from thyroid cancer patients after iodine-131 therapy / G.O. Monteiro, N.G. Oliveira, A.S. Rodrigues [et al.] // Int. J. Cancer. – 2002. – Vol. 102, № 6. – P. 556-561. https://doi.org/10.1002/ijc.10768

Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131 / M. Ballardin, F. Gemignani, L. Bodei [et al.] // Mutal. Res. – 2002. – V. 514, № 1-2. – P. 77-85. https://doi.org/10.1016/s1383-5718(01)00323-0

Cytokinesis-block mickonucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma / L. Popova, V. Hadjidekova, T. Hadjieva [et al.] // Hell. J. Nucl. Med. – 2005. – V. 8, № 1. – P. 54-57.

Воронцова Т. В. Состояние имунной системы детей больных раком щитовидной железы, получающих гормональное лечение и радиойодтерапию / Т. В. Воронцова, О. О. Янович, Е. П. Демидчик // Иммунология, аллергология, инфектология. – 2001. – № 2. – С. 38-45.

Ионизирующее излучение и иммунная система у детей / Е. М. Лукьянова, Ю. А. Антипкин, В. П. Чернышев [и др.] // Киев: Эксперт. – 2003. – С. 111-175.

Бережная Н. М. Иммунология злокачественного роста / Н. Бережная, В. Чехун – К.: Наукова думка, 2005. – 792 с.

Роль цитокинов в осуществлении апоптотических процессов клеток иммунной системы у лиц, подвергшихся воздействию ионизирующей радиации в малых дозах / О. С. Солнцева, Н. В. Калинина, Н. В. Бычкова [и др.] // Иммунология. – 2000. – № 3. – С. 22-24.

De Vos C. A simple rapid method for detection of IL-2 in a physiological medium / C. De Vos, W. Libert // J. Immunol. Meth. – 1984. – Vol. 74, № 2. – P. 375-384. https://doi.org/10.1016/0022-1759(84)90306-5


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24026/1818-1384.3(36).2011.86689



Creative Commons License
Ця робота ліцензована Creative Commons Attribution-NonCommercial 4.0 International License.

© Клінічна ендокринологія та ендокринна хірургія.

ISSN: 1818-1384 (Print), e-ISSN: 2519-2582, DOI: 10.24026/1818-1384.

При копіюванні активне посилання на матеріал обов'язкове.

Flag Counter